Go to Market, Launch Readiness

Go to Market, launch preparation is major transition from clinical development to commercialization of the pipeline. Regardless of the scale of organization, such transition is a major challenge because of lack of resources, network, experience in the disease area, insight gaps and lack of competitive information at the beginning. Medical affairs function is a key asset driving the transition for commercialization, ideally 36 to 24 months ahead to actual launch date, in collaboration with clinical development, commercial, regulatory and market access teams.

  • Start Simple and Win Early
  • Define key scientific messages to engage consistently
  • Focus on patients outcome but not data only.
  • Personal HCP experience is key
  • Proactively focus on stakeholder expectations
  • Collaborate with scientific societies to support Life Cycle of the portfolio.
This website uses cookies and asks your personal data to enhance your browsing experience. We are committed to protecting your privacy and ensuring your data is handled in compliance with the General Data Protection Regulation (GDPR).